All Curated Mutation Sites in HIV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All
  
IN
  
RT
  
LTR
  
CA
  
Gag
  
Nef
  
Env
  
gp120
  
gp160
  
gp41
  
gp140
  
MA
  
Pol
  
PR
  
Rev
  
Tat
  
Vpu
  
Vif
  
Vpr
  

Keyword: Cell line-30808702
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 30808702 A583T
Env
Env
Cell line
G
R
S
View
2 30808702 C17T
LTR
Cell line
G
R
S
View
3 30808702 C206X
Nef
Nef
Cell line
G
R
S
View
4 30808702 C9007A
LTR
Cell line
G
R
S
View
5 30808702 E12K
Gag
Gag
Cell line
D
G
R
S
View
6 30808702 E40K
Gag
Gag
Cell line
D
G
R
S
View
7 30808702 E434K
Env
Env
Cell line
G
R
S
View
8 30808702 E59K
Nef
Nef
Cell line
G
R
S
View
9 30808702 I223T
Gag
Gag
Cell line
D
G
R
S
View
10 30808702 I520M
Env
Env
Cell line
G
R
S
View
11 30808702 K660E
Env
Env
Cell line
G
R
S
View
12 30808702 L491V
Pol
gag-pol
Cell line
G
R
S
View
13 30808702 N306K
Env
Env
Cell line
G
R
S
View
14 30808702 Q555H
Env
Env
Cell line
G
R
S
View
15 30808702 R361K
Gag
Gag
Cell line
D
G
R
S
View
16 30808702 R538A
Env
Env
Cell line
G
R
S
View
17 30808702 V142I
Vif
Vif
Cell line
G
R
S
View
Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.